ArticleAnnals of transplantation2022

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study.

Bruno Roche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.